WASHINGTON : A drug made of using nanotechnology and a fungus tarnished some laboratory experiments might be widely effective against a range of cancers, The U.S researchers said on Sunday.
The drug known Lodamin had been improved in one of the last experiments investigated by Dr. Judah Folkman, a cancer researcher who died in January. Folkman led the idea of angiogenesis therapy ravenous tumors by holding over them from rising blood supplies.
Lodamin is an angiogenesis inhibitor that Folkman’s team has been running just right for 20 years. Writing in the journal Nature Biotechnology, his colleagues said they developed a formula working as a pill with no side-effects.
Tests in mice showed it worked against a range of cancers including breast cancer, neuroblastoma, ovarian cancer, prostate cancer, brain tumors called as glioblastomas and uterine tumors.